China Biologic's Former CEO Leads $3.9B Takeover Bid
China Biologic Products Holdings Inc. has received a $3.9 billion cash offer from its former chief executive and a consortium of investment firms, according to U.S. Securities and Exchange Commission filings...To view the full article, register now.
Already a subscriber? Click here to view full article